Observational study / 2011
A change in multivitamin formulation containing added citrus bioflavonoids was linked to a significant increase in complaints of nausea and vomiting.
A retrospective observational study examined adverse event complaints in a weight loss program (over 95% women) 3 months before and 3 months after switching multivitamin suppliers. Complaints of nausea and vomiting increased from 2 (out of 88,252 patients) to 166 (out of 88,468 patients; P < 0.0001), rash increased from 0 to 9 (P < 0.02), and total complaints increased from 11 to 194 (P < 0.0001). The reformulated multivitamin contained added citrus bioflavonoids, which inhibit cytochrome P450 enzyme systems and decrease clearance of exogenous estrogens, suggesting a potential drug interaction in women taking oral contraceptives or hormone replacement therapy.
Shows an association, not proof of cause and effect.
- Study type
- Retrospective observational study
- Who was studied
- Clients in a commercial weight loss program (>95% women; 88,252 before vs 88,468 after)
- What was measured
- Incidence of nausea and vomiting, rash, and total adverse complaints
THE PAPER
Vomiting from multivitamins: a potential drug interaction.
Greenway F, Fujioka K, Yu Y. Am J Ther, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.